Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

SELL
$20.49 - $39.72 $82,800 - $160,508
-4,041 Closed
0 $0
Q1 2022

Apr 27, 2022

SELL
$28.19 - $46.6 $10,092 - $16,682
-358 Reduced 8.14%
4,041 $149,000
Q4 2021

Jan 31, 2022

BUY
$41.2 - $73.6 $181,238 - $323,766
4,399 New
4,399 $200,000
Q4 2019

Jan 27, 2020

SELL
$19.24 - $28.41 $321,712 - $475,043
-16,721 Closed
0 $0
Q3 2019

Oct 28, 2019

SELL
$20.03 - $40.08 $35,913 - $71,863
-1,793 Reduced 9.68%
16,721 $378,000
Q2 2019

Jul 30, 2019

BUY
$25.78 - $39.77 $477,290 - $736,301
18,514 New
18,514 $666,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.